NCT05566964Completed
Descriptive Analysis of Real-world Data Collected with ME&MGopen
Descriptive Analysis of Real-world Data Collected with the ME&MGopen Mobile Application Developed for Myasthenia Gravis Patients
Source: ClinicalTrials.gov · Last updated 10 Mar 2025
Brief summary (registry, in English)
The ME\&MGopen smartphone application is an investigational software for research purposes only, developed by Ad Scientiam. It features digital tests to assess the respiratory capacity ("My Breathing" Test), dysarthria ("My Voice" Test), ptosis ("My eyelids" test), as well as upper and lower limb muscle function ("My arms" Test and "My legs" Test). The mobile app also includes e-questionnaires related to activities of daily living, pain, insomnia, quality of life and depression. The objectives of the study are to collect data on patients' symptoms with the application in a real life setting, to assess adherence to the use of the tool, user experience and satisfaction with the application, and safety of use.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 236 (actual)
- First submitted
- 7 Sept 2022
- Start date
- 27 Feb 2023
- Primary completion date
- 10 Jan 2025
- Lead sponsor
- Ad scientiam
- Diseases
- Myasthenia gravis
- NCT number
- NCT05566964
What you commit to
- Study type: Observational
- Participants enrolled: 236
- From 27 Feb 2023 to the primary completion date, 10 Jan 2025
- 3 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- A medical, psychological, or behavioral condition which interferes with compliance
Age
- Aged 17 years or younger
Other
- Participating in another ME\&MG trial
Who the study is looking for
- Aged 18 + years old
- Diagnosis of gMG with positive serologic test for anti-AChR autoantibody at screening
- Who has read the information sheet and signed the informed consent form
- Owns a personal smartphone which version is above 14 for IOS and 8 for Android included
- Able to use a smartphone
- Able to perform the ME\&MG tests (based on investigator's judgment)
- Able to read language in which the mobile application is available (English, Spanish, German) and able to understand pictograms
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Health Network Coordinator of this site? Confirm its status | Toronto | Canada | Unknown status |
| Lindus Health Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| The University of North Carolina at Chapel Hill Coordinator of this site? Confirm its status | Chapel Hill | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.